HCXY Market Analysis

News & Sentiment

44 articles · sorted by date
Page 1 of 3 · 44 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio19.41
EPS (TTM)0.0% YoY
Profit margin0.0%FINANCIALS
Market cap$1.31BSmall cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
0.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
5.0%
Beta
Last earnings
Oct 30, 2025 · Estimate $0.00 · Reported $0.63
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Hercules Capital, Inc.

Company profile

Hercules Capital, Inc. (HCXY) is a leading publicly traded business development company that focuses on providing tailored financing solutions primarily to the life sciences and technology sectors. With a commitment to capital preservation and achieving risk-adjusted returns, Hercules leverages its deep industry knowledge and strategic alliances to offer both debt and equity investments that support innovation and growth. By strategically identifying high-potential firms in competitive markets, Hercules positions itself as an appealing financial partner for institutional investors aiming for…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
NONE
Fiscal year end
December
Latest quarter
Jun 30, 2026
Market cap$1.31B
Shares outstanding$0
52W high$25.06
52W low$23.31

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer